Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Want to make money fast? Discover effective ways to make money in just 5 days and enhance your financial situation. Start your journey today!
15,935 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Travelers are receiving emails that imitate real reservations, complete with names, dates, and confirmation numbers. ...
Investors and policymakers are debating the impact of politicians’ stock holdings as volatility grips markets. Expert...
Two powerhouse index funds—VOO and QQQ—pose a classic choice for long-term investors. This guide breaks down growth p...
AI is reshaping the backbone of technology. This article flags three infrastructure stocks that could double by 2027 ...
Retirees often rely on Social Security as a lifeline. A potential 3.8% COLA in 2027 could lift monthly checks, but th...
A Hong Kong-based firm disclosed a $436 million stake in BlackRock’s IBIT, highlighting how offshore capital channels...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Tariffs grabbed headlines, but markets can react to other forces just as sharply. This guide breaks down two addition...
Market swings push many investors toward complexity. This article reveals a simple, cost-efficient core holding: a Va...